User Tools

Site Tools


labs:coronavirus_live_tracking

Coronavirus (COVID-19) Live Tracking, IIRESS Labs, 2020

COVID-19 Epidemiology & Transmission Information - History of Discovery

Pre-COVID-19:SARS-CoV-1 | Dec. 2019/Jan. 2020 Archives | February 2020 Archives | March 2020 Archives | April 2020 Archives | May 2020 Archives

*Note: Pre-print articles have not yet been peer-reviewed and their results are subject to change or retraction. While they can be useful indicators of the direction of current research, waiting for full peer-review results is the best practice when making clinical or critical research decisions.

(Updated 07/16/2020)


COVID-19 Quick Stats

Quick Facts

Coronavirus disease 2019 (COVID-19) is the disease caused by the virus SARS-CoV-2

SARS-CoV-2 is closely related to the viruses that cause SARS and MERS, which have both caused severe outbreaks of respiratory disease.

Case Fatality Rate (CFR) for COVID-19 in the US seems relatively stable at 5.7%, Italy/Spain/France/UK at 10-15%.

  • Case fatality rate is the proportion of attributable number of deaths from a disease to reported (clinical) cases.

Infection Fatality Rate (IFR) for COVID-19 in the US is estimated to be between 0.5% and 1.0% globally (Meyerowitz-Katz, 2020 - Pre-Print).

  • Infection fatality rate (IFR) is the proportion of attributable number of deaths to all those infected (includes sub-clinical and asymptomatic cases) and is expected to be lower than CFR.
  • This number can be estimated during an epidemic/pandemic from antibody (by determining seroprevalence) studies.
  • SARS-CoV-2 has a very high asymptomatic rate that makes it difficult to estimate this number, meaning that estimates will vary widely between region and testing methodology.

Seroprevalence is the prevalence of individuals with antibodies to SARS-CoV-2 in a population, meaning the percent of individuals that have or have recently had the disease, regardless of disease status (asymptomatic, sub-clinical, or full-clinical presentation).

  • Current seroprevalence estimates range from 1.5% up to 30%, varying from region and testing methodology (Levesque and Maybury, 2020), meaning that a greater portion of any given population is infected with SARS-CoV-2 than will be identified from routine testing.
  • Widespread seroprevalence of SARS-CoV-2 antibodies is not currently known with scientific certainty in the US.

Mortality rate is the attributable rate of deaths due to a disease in a population (e.g., out of 100,000 people what is the risk of death for a particular disease).

  • This number is not typically estimated until after an epidemic/pandemic.
  • Mortality rate of COVID-19 is not currently known with scientific certainty in the US.

Table 1. IIRESS Labs running COVID-19 Estimated CFR (CFR) - 06/07/2020

Country Infections Deaths CFR 95% Confidence Interval
USA 1,942,363 110,514 5.69% (5.66 - 5.72%)
Brazil 691,758 36,455 5.27% (5.22 - 5.32%)
Russia 467,073 5,851 1.25% (1.22 - 1.28%)
UK 287,621 40,625 14.12% (14.00 - 14.25%)
India 257,486 7,207 2.80% (2.74 - 2.86%)
Spain 241,550 27,136 11.23% (11.11 - 11.36%)
Italy 234,998 33,899 14.43% (14.28 - 14.57%)
Peru 196,515 5,465 2.78% (2.71 - 2.85%)
France 191,102 29,158 15.26% (15.10 - 15.42%)
Germany 185,750 8,685 4.68% (4.58 - 4.77%)
Iran 171,789 8,281 4.82% (4.72 - 4.92%)
Turkey 170,132 4,692 2.76% (2.68 - 2.84%)
China 84,191 4,638 5.51% (5.35 - 5.66%)
South Korea 11,814 273 2.31% (2.04 - 2.58%)
Australia 7,265 102 1.4% (1.13 - 1.67%)
Global 7,009,065 402,730 5.75% (5.73 - 5.76%)

Johns Hopkins Center for Systems Science and Engineering, Coronavirus (COVID-19) Live Map: Source


Published estimates of COVID-19 CFR, IFR, and Mortality Rate

Estimates of Case Fatality Rate (CFR)

Estimates of Mortality Rate

Estimates of Infection Fatality Rate (IFR)

(Updated 05/09/2020)


Clinical Pathology of COVID-19

Clinical Pathology Archives

Immune System Function

Digestive Symptoms

Sensory Dysfunction (Loss of smell and taste)

Detection Assays

Corticosteroids

Patient-Derived Mutation Pathogenecity

News/Journal Shortname Key Guide

(Updated 04/19/2020)


COVID-19 Clinical Trials (Vaccine, Treatment, Testing, etc.)

Vaccine Development

Vaccine Trials

Testing Methodology

(Updated 05/02/2020)


Genetic Epidemiology of COVID-19

Genetic epidemiology of COVID-19, nextstrain.org

Figure 5. Sequence diversity of 3,170 SARS-CoV-2 strains during the 2019/2020 global coronavirus pandemic (Source: http://www.nextstrain.org)

(Updated 04/22/2020)


Coronavirus Specific Podcasts (The Planetary News Radio, an IIRESS Media Production)

The Planetary News Radio - Episode 19: Global Coronavirus (COVID-19) Pandemic Update 3 (3/31/2020)

The Planetary News Radio - Episode 18: Global Coronavirus (COVID-19) Pandemic Update 2 (3/20/2020)

The Planetary News Radio - Episode 17: Global Coronavirus (COVID-19) Pandemic Update 1 (3/14/2020)

Today's episode is a special feature episode of the Planetary News Radio. It is in times of great need that scientists and community members must join together to protect the community, whether that is at the national level, state level, city, or friends and family. As you all know, the coronavirus (COVID-19) has rapidly spread around the world, and we are seeing increasingly sweeping government responses to this outbreak, including quarantines, travel restrictions, and the bolstering of healthcare services. Listen to my status update on the pandemic here in Corvallis, Oregon, as well as a global perspective. For more coronavirus data analytics and updates, visit http://ncov.iiress.com. For transcripts and show notes, visit on the web at: http://www.iiress.com/planetary/podcasts.


COVID-19 General Information/Data Sources

Coronavirus E-mail Updates and GoFundMe info

Sign up for COVID-19 Updates

* indicates required


THANK YOU TO THE JUICE MEDIA FOR GILDING ME: https://youtu.be/Hks6Nq7g6P4

labs/coronavirus_live_tracking.txt · Last modified: 2020/07/26 05:24 by bpwhite